Clinical Trial Update: Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating apremilast as an anti-pruritic treatment for prurigo nodularis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Tanja Todberg, MD | Conditions: Prurigo Nodularis | Phase 1, Phase 2 | Status: UNKNOWN